
Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
Author(s) -
Rebecca C. Coll,
Luke A. J. O’Neill
Publication year - 2013
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/annotation/9f221489-155d-4978-a36d-30c51853e438
Subject(s) - aim2 , inflammasome , drug , inhibitory postsynaptic potential , chemistry , pharmacology , biology , immunology , inflammation , neuroscience